TGFB1 and prostate carcinoma: In turn, 1,25(OH)2D3 suppressed negative regulators of TGFβ availability, including latent TGFβ binding protein 1 (LTBP1) in OVCAR3 cells [125] andprimary prostate cancer cells [121].